Arkema SA (OTCMKTS:ARKAY - Get Free Report) has received a consensus rating of "Reduce" from the eight research firms that are currently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and one has given a buy recommendation to the company.
Several research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Arkema in a report on Tuesday, June 23rd. The Goldman Sachs Group downgraded Arkema from a "buy" rating to a "neutral" rating in a research report on Monday, June 8th. Zacks Research raised Arkema from a "strong sell" rating to a "hold" rating in a research note on Monday, May 4th. Sanford C. Bernstein upgraded Arkema from a "strong sell" rating to a "hold" rating in a report on Monday, April 20th. Finally, Kepler Capital Markets downgraded Arkema from a "hold" rating to a "strong sell" rating in a research note on Thursday, May 7th.
Read Our Latest Stock Analysis on ARKAY
Arkema Trading Up 0.9%
ARKAY stock opened at $62.86 on Thursday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.64. Arkema has a 1-year low of $56.28 and a 1-year high of $79.36. The business has a 50 day simple moving average of $66.62 and a two-hundred day simple moving average of $67.01. The company has a market capitalization of $4.78 billion, a price-to-earnings ratio of 251.44 and a beta of 0.86.
Arkema (OTCMKTS:ARKAY - Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The basic materials company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.10. Arkema had a net margin of 0.46% and a return on equity of 4.06%. The firm had revenue of $2.57 billion for the quarter, compared to analysts' expectations of $2.52 billion. Research analysts anticipate that Arkema will post 3.48 EPS for the current fiscal year.
About Arkema
(
Get Free Report)
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total's chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema's operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.